Landos Biopharma
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Landos Biopharma's balance sheet done over the years? Its assets were worth $38,040,000 last year, which is less than in the previous period. 16% of Landos Biopharma’s total assets is currently financed by debt. Its liabilities reached the amount of $6,249,000, which means an increase by 2% compared compared to last year.

Debt to Assets

Landos Biopharma, Inc. (NASDAQ:LABP): Debt to assets
2018 2796000 1.79M 64.23%
2019 50480000 76.06M 150.68%
2020 30332000 84.34M 278.08%
2021 92879000 16.61M 17.88%
2022 45253000 6.12M 13.53%
2023 38040000 6.24M 16.43%

LABP Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
37.54M36.64M8.30M2.41M9.80M359K
Short term investments
07.76M82.57M25.71M40.15M0
Net receivables
000154K1K2.09M
Inventory
0001.39M00
Other current assets
491K851K1.26M202K144K41K
Total current assets
38.04M45.25M92.14M29.88M50.11M2.49M
Non-current assets:
Property, Plant and Equipment
00707K444K359K304K
Goodwill
000000
Intangible assets
000000
Long term investments
000000
Other non-current assets
0026K011K0
Total non-current assets
00733K444K370K304K
Total assets
38.04M45.25M92.87M30.33M50.48M2.79M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
000000
Short term debt
000000
Total current liabilities
6.24M6.12M16.61M11.03M3.02M1.79M
Non-current liabilities:
Long term debt
000000
Deferred tax
000000
Other non-current liabilities
03.43M073.31M00
Total non-current liabilities
03.43M073.31M73.03M0
Total liabilities
6.24M6.12M16.61M84.34M76.06M1.79M
Data sourceData sourceData sourceData source